Clinical Trial Update: A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the pharmacokinetics/pharmacodynamics of Avycaz (ceftazidime/avibactam) in critically ill ICU patients has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharmacokinetics in Critically Ill Patients

Drugs mentioned

• Avycaz (ceftazidime-avibactam)

Snippet

Sponsor: Michigan State University | Conditions: Pharmacokinetics of Avycaz in ICU Patients | Phase 1 | Status: COMPLETED | Results posted: 2019-03-06